Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-cont... by Ledermann, Jonathan A, Prof, Harter, Philipp, MD, Gourley, Charlie, Prof, Friedlander, Michael, Prof, Vergote, Ignace, Prof, Rustin, Gordon, Prof, Scott, Clare, PhD, Meier, Werner, Prof, Shapira-Frommer, Ronnie, MD, Safra, Tamar, MD, Matei, Daniela, MD, Fielding, Anitra, MBChB, Spencer, Stuart, MSc, Rowe, Philip, MSc, Lowe, Elizabeth, MD, Hodgson, Darren, PhD, Sovak, Mika A, MD, Matulonis, Ursula, MD

Get full text

Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary perito... by Burger, Robert. A, Brady, Mark F, Rhee, Joon, Sovak, Mika A, Kong, George, Nguyen, Hoa P, Bookman, Michael A

Get full text

Vandetanib Plus Chemotherapy for Induction Followed by Vandetanib or Placebo As Maintenance for Patients with Advanced Non–Small-Cell Lung Cancer: A Randomized Phase 2 PrECOG Study... by Aisner, Joseph, Manola, Judith B., Dakhil, Shaker R., Stella, Philip J., Sovak, Mika A., Schiller, Joan H.

Get full text

Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study by Sovak, Mika A, Hensley, Martee L, Dupont, Jakob, Ishill, Nicole, Alektiar, Kaled M, Abu-Rustum, Nadeem, Barakat, Richard, Chi, Dennis S, Sabbatini, Paul, Spriggs, David R, Aghajanian, Carol

Get full text

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors by Simon, George R., Ilaria, Robert L., Sovak, Mika A., Williams, Charles C., Haura, Eric B., Cleverly, Ann L., Sykes, Amanda K., Wagner, Margaret M., de Alwis, Dinesh P., Slapak, Christopher A., Miller, Mary A., Spriggs, David R.

Get full text

Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer by Sovak, Mika A., Lutzker, Stuart, Zheng, Ling, Guensch, Lisa, Joyce, Margaret, Schwartz, Susan, Wu, Yujun, Aisner, Joseph

Get full text

Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells by Kim, Dong W., Sovak, Mika A., Zanieski, Gregory, Nonet, Genevieve, Romieu-Mourez, Raphaëlle, Lau, Alan W., Hafer, Laurie J., Yaswen, Paul, Stampfer, Martha, Rogers, Adrianne E., Russo, Jose, Sonenshein, Gail E.

Get full text

P2-225: A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC) by Sovak, Mika A., Lutzker, Stuart, Guensch, Lisa, Joyce, Margaret, Schwartz, Susan, Wu, Yujun, Zheng, Ling, Aisner, Joseph

Get full text

Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells by Kim, D W, Sovak, M A, Zanieski, G, Nonet, G, Romieu-Mourez, R, Lau, A W, Hafer, L J, Yaswen, P, Stampfer, M, Rogers, A E, Russo, J, Sonenshein, G E

Get full text

Activation of NF-kappa B/Rel occurs early during neoplastic transformation of mammary cells by Kim, Dong .W., Sovak, Mika A., Zanieski, Gregory, Nonet, Genevieve, Romieu-Mourez, Raphaelle, Lau, Alan W., Hafer, Laurie J., Yaswen, Paul, Stampfer, Martha, Rogers, Adrianne E., Russo, Jose, Sonenshein, Gail E.

Get full text

Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach by Mehnert, Janice M, Tan, Antoinette R, Moss, Rebecca, Poplin, Elizabeth, Stein, Mark N, Sovak, Mika, Levinson, Kelly, Lin, Hongxia, Kane, Michael, Gounder, Murugesan, Lin, Yong, Shih, Weichung Joe, White, Eileen, Rubin, Eric H, Karantza, Vassiliki

Get full text